National HealthCare Stock Statistic Functions Beta
| NHC Stock | USD 155.88 -0.46 -0.29% |
| Symbol |
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on National HealthCare correlated with the market. If Beta is less than 0 National HealthCare generally moves in the opposite direction as compared to the market. If National HealthCare Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one National HealthCare is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of National HealthCare is generally in the same direction as the market. If Beta > 1 National HealthCare moves generally in the same direction as, but more than the movement of the benchmark.
National HealthCare Technical Analysis Modules
Most technical analysis of National HealthCare help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for National from various momentum indicators to cycle indicators. When you analyze National charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Stock Overview, Methodology & Data Sources
National HealthCare Corporation operates, manages, and provides services to skilled nursing facilities, assisted living facilities, independent living facilities, homecare and hospice agencies, and a behavioral health hospital. National HealthCare Corporation was founded in 1971 and is based in Murfreesboro, Tennessee. National Healthcare operates under Medical Care Facilities classification in the United States and is traded on AMEX Exchange. It employs 12965 people. As a mid-cap equity, National HealthCare is reviewed for growth durability, margin stability, and risk discipline. Current metrics include P/E of 22.85, P/B of 2.27, profit margin of 6.75%. National HealthCare has a market cap of 1.96 B, P/E of 22.85, ROE of 10.12%.
Methodology
Unless otherwise specified, financial data for National HealthCare is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. National (USA Stocks:NHC) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: Underlying inputs rely on public filings and market reference sources, including disclosures from U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Food & Drug Administration (FDA). Values may reflect publication timing differences. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
National HealthCare may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.
This content is curated and reviewed by:
Raphi Shpitalnik - Junior Member of Macroaxis Editorial BoardBe your own money manager
Tracking National HealthCare inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.
Generate Optimal Portfolios
Align your risk and return expectations
More Resources for National Stock Analysis
Understanding National HealthCare typically begins with financial statements and long-term trend review. Key ratios help frame profitability, efficiency, and growth context for National HealthCare Stock. Selected reports below provide context for National Stock:National HealthCare has a market cap of 1.96 B, operating margin of 7.94%, ROE of 10.12%. Use Correlation Analysis to explore allocation context. This includes a position in National HealthCare within the allocation view. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. Interested in buying National Stock? Our How to Buy National HealthCare guide covers everything you need to know.Analysis related to National HealthCare should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Quarterly Earnings Growth -0.08 | Dividend Share 2.5 | Earnings Share 6.48 | Revenue Per Share | Quarterly Revenue Growth 0.125 |
National HealthCare's market price can diverge from book value, the accounting figure shown on National's balance sheet. National HealthCare's market capitalization is 1.96 B. A P/B ratio of 2.27 indicates the market values National HealthCare above its accounting book value. Enterprise value stands at 2.26 B. Intrinsic value represents an estimate of underlying worth and can differ from both market price and book value. Valuation methods compare these perspectives to frame context.
Note that National HealthCare's intrinsic value and market price are different measures derived from different inputs. For National HealthCare, key inputs include a P/E ratio of 22.85, a P/B ratio of 2.27, a profit margin of 6.75%, and ROE of 10.12%. By contrast, market price reflects the level where buyers and sellers transact.